The invention is based on the discovery that specific dosages of pyrimidine compositions, such as uridine compositions, can be used to treat patients diagnosed with bipolar disorder.

 
Web www.patentalert.com

< Methods for gauging the effect of a depression treatment by determining the levels of beta-arrestin 1 and G-protein coupled receptor kinase 2

< Multiparticulate compositions with improved stability

> Therapeutic agents useful for treating pain

> Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
~ 00615